Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma Meeting Abstract
| Authors: | Ip, A.; Gutierrez, M.; Warren, M. E.; Pfister, D. G.; Brady, O.; Shen, R. L.; Riely, G. J. |
| Abstract Title: | Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304295 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.e21045 |
| Notes: | Meeting Abstract: e21045 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
